Warfarin News and Research

RSS

Warfarin is a drug that prevents blood from clotting. It belongs to the family of drugs called anticoagulants (blood thinners).

Women at greater risk of subsequent stroke than men

Among patients who have suffered a single stroke, researchers at the University of Pennsylvania School of Medicine, along with colleagues at other institutions, have found that severe stenosis, or narrowing, of the arteries in the head represents a major risk factor for the development of a subsequent stroke.

27 Jan 2006

$Warfarin increases risk of bone fracture$

Warfarin increases risk of bone fracture

Elderly patients taking the commonly prescribed blood thinner warfarin experience an increased risk for osteoporosis-linked bone fractures, according to a study at Washington University School of Medicine in St. Louis.

23 Jan 2006

Rush University Medical Center to use new stent specifically designed for use in the brain to reduce the threat of stroke

Rush University Medical Center is the first site in Illinois to use the first stent specifically designed for use in the brain. While it has been possible to attempt to open narrowed brain vessels using existing stents made of stainless steel and intended for use in the heart, the new Wingspan brain stent is designed to be gentler on the more fragile brain vessels.

23 Jan 2006

New version of diet drug not suitable for some

According to the U.S. Food and Drug Administration a version of the diet drug Xenical, which will be available without a prescription, may be not be suitable for some people.

23 Jan 2006

Pharmacogenetics can reduce health care costs

Chances are good that a medication you take is one of several drugs that can be affected by genetic factors, according to researchers at Washington University School of Medicine in St. Louis and the St. Louis College of Pharmacy.

5 Jan 2006

Heart patients, do you tell your doctor you're using alternative medicines?

Doctors, do you ask your patients if they're using alternative medicines?

21 Nov 2005

Ibuprofen and naproxen combined with aspirin increase risk of gastrointestinal complications

Patients who combine the common over-the counter pain medications ibuprofen and naproxen with aspirin have a risk of gastrointestinal complications including ulcers, perforations and bleeding that is two to three times greater than patients who take these medications but do not combine them with aspirin.

1 Nov 2005

Research points way to more effective delivery of medicine around the body

New research showing how drugs stick to a key protein in the bloodstream could help to create drugs that are delivered more effectively to organs in the body.

13 Oct 2005

Myriad Genetics nears completion of antithrombin drug trial

Myriad Genetics announced today that it is rapidly nearing completion of the preclinical data package on MPC-0920, its antithrombin drug candidate, for submission to the FDA prior to beginning human clinical trials.

11 Oct 2005

Important new lessons learned from aspirin

No other medicine is as common, inexpensive, and yet powerful in so many ways as aspirin; yet despite a century of experience with the drug, researchers are still learning important new lessons, while raising new questions, according to seven special articles in the Sept. 20, 2005, issue of the Journal of the American College of Cardiology.

20 Sep 2005

Women with atrial fibrillation face a higher risk of ischemic stroke than men

Women with atrial fibrillation who are not on anticoagulant therapy have a higher rate of ischemic stroke and face a higher absolute risk for stroke than do men with the condition, according to a joint study

19 Sep 2005

Doctors call for education programmes for health professionals and patients about available over-the-counter (OTC) medicines

In a British Medical Association (BMA) report launched today (14 June 2005) doctors are calling for education programmes for health professionals and patients about available over-the-counter (OTC) medicines.

13 Jun 2005

Genetic variation alters response to anti-clotting drug warfarin

Millions of people take the anticoagulant drug warfarin to prevent harmful clotting after a heart attack, stroke, or major surgery. But the proper dose of warfarin can vary greatly and can be hard to predict.

1 Jun 2005

Patients at high risk of stroke may need to continue Warfarin therapy after heart rhythm is controlled

Treatment with warfarin, a medication that prevents blood clotting, may reduce the risk of stroke by more than two-thirds in patients with atrial fibrillation (AF), a condition which places them at high risk of stroke, according to a study in the May 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

23 May 2005

New discovery sparks hope of safer dosage of Warfarin

The blood-thinning drug Warfarin tops the list of drug side-effects in Sweden. Patient sensitivity to Warfarin varies, which can lead to over-dosage and in certain cases to death.

17 May 2005

Ranbaxy settles NHS generic drug claim

Britain's Department of Health and Ranbaxy (UK) Ltd have jointly announced settlement of the claims brought against Ranbaxy for alleged anti-competitive cartel conduct in connection with the supply to the NHS of generic drugs between 1996 and 2000.

4 Apr 2005

Aspirin safer than Warfarin for treating blocked arteries

National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health (NIH), have shown for the first time that aspirin works as well as warfarin in reducing blood clotting. Until now doctors have lacked good evidence for choosing one therapy over the other.

30 Mar 2005